A. N. Afuah and J. M. Utterback, Responding to Structural Industry Changes: A Technological Evolution Perspective, Industrial and Corporate Change, vol.6, issue.1, pp.183-202, 1997.
DOI : 10.1093/icc/6.1.183

R. Agarwal and B. L. Bayus, The Market Evolution and Sales Takeoff of Product Innovations, Management Science, vol.48, issue.8, pp.1024-1041, 2002.
DOI : 10.1287/mnsc.48.8.1024.167

R. Agarwal and M. Tripsas, Technology and Industry Evolution, Handbook of Technology and Innovation Management, 2008.

M. Allarakhia and S. Walsh, Managing knowledge assets under conditions of radical change: The case of the pharmaceutical industry, Technovation, vol.31, issue.2-3, pp.105-117, 2011.
DOI : 10.1016/j.technovation.2010.11.001

A. Amir-aslani and V. Mangematin, The future of drug discovery and development: Shifting emphasis towards personalized medicine, Technological Forecasting and Social Change, vol.77, issue.2, pp.203-217, 2010.
DOI : 10.1016/j.techfore.2009.09.005

URL : https://hal.archives-ouvertes.fr/hal-00749148

J. Anand, R. Oriani, and R. S. Vassolo, Alliance Activity as a Dynamic Capability in the Face of a Discontinuous Technological Change. Organization Science Forthcoming, 2010.

P. Anderson and M. L. Tushman, Technological Discontinuities and Dominant Designs: A Cyclical Model of Technological Change, Administrative Science Quarterly, vol.35, issue.4, pp.604-633, 1990.
DOI : 10.2307/2393511

A. Arora and A. Gambardella, The changing technology of technological change: general and abstract knowledge and the division of innovative labour, Research Policy, vol.23, issue.5, pp.523-532, 1994.
DOI : 10.1016/0048-7333(94)01003-X

C. Baden-fuller, B. Demil, and X. Lecocq, Editorial, Long Range Planning, vol.43, issue.2-3, pp.143-145, 2010.
DOI : 10.1016/j.lrp.2010.03.002

M. J. Benner, Process Management and Technological Innovation: A Longitudinal Study of the Photography and Paint Industries, Administrative Science Quarterly, vol.47, issue.4, p.676, 2002.
DOI : 10.2307/3094913

M. J. Benner, Securities Analysts and Incumbent Response to Radical Technological Change: Evidence from Digital Photography and Internet Telephony, Organization Science, vol.21, issue.1, pp.42-62, 2010.
DOI : 10.1287/orsc.1080.0395

R. A. Bettis and C. K. Prahalad, The dominant logic: Retrospective and extension, Strategic Management Journal, vol.10, issue.1, pp.5-14, 1995.
DOI : 10.1002/smj.4250160104

M. Bianchi, A. Cavaliere, D. Chiaroni, F. Frattini, and V. Chiesa, Organisational modes for Open Innovation in the bio-pharmaceutical industry: An exploratory analysis, Technovation, vol.31, issue.1, pp.22-33, 2011.
DOI : 10.1016/j.technovation.2010.03.002

D. A. Bosse and S. A. Alvarez, Bargaining power in alliance governance negotiations: evidence from the biotechnology industry, Technovation, vol.30, issue.5-6, pp.367-375, 2010.
DOI : 10.1016/j.technovation.2010.01.003

R. Bradfield and H. El-sayed, Four scenarios for the future of the pharmaceutical industry, Technology Analysis & Strategic Management, vol.21, issue.2, pp.195-212, 2009.
DOI : 10.1080/09537320802625280

V. Briquet-laugier and M. Ott, Des nanobiotechnologies à la nanomédecine du futur, BioFutur, vol.265, pp.57-62, 2006.

R. Casadesus-masanell and J. E. Ricart, From Strategy to Business Models and onto Tactics, Long Range Planning, vol.43, issue.2-3, pp.2-3, 2010.
DOI : 10.1016/j.lrp.2010.01.004

C. Curran, S. Bröring, and J. Leker, Anticipating converging industries using publicly available data, Technological Forecasting and Social Change, vol.77, issue.3, pp.385-395, 2010.
DOI : 10.1016/j.techfore.2009.10.002

. Datamonitor, Global Pharmaceuticals, Biotechnology & Life Sciences Industry Profile: Reference, vol.code, pp.199-2357, 2010.

D. George and R. T. , Abstract:, Business Ethics Quarterly, vol.15, issue.04, pp.549-575, 2005.
DOI : 10.5840/beq200515444

B. Demil and X. Lecocq, Business Model Evolution: In Search of Dynamic Consistency, Long Range Planning, vol.43, issue.2-3, pp.2-3, 2010.
DOI : 10.1016/j.lrp.2010.02.004

URL : https://hal.archives-ouvertes.fr/hal-00572915

C. Dhanaraj and A. Parkhe, ORCHESTRATING INNOVATION NETWORKS., Academy of Management Review, vol.31, issue.3, pp.659-669, 2006.
DOI : 10.5465/AMR.2006.21318923

J. Dimasi and H. G. Grabowski, The cost of biopharmaceutical R&D: is biotech different?, Managerial and Decision Economics, vol.13, issue.4-5, pp.469-479, 2007.
DOI : 10.1002/mde.1360

J. A. Dimasi, R. W. Hansen, and H. G. Grabowski, The price of innovation: new estimates of drug development costs, Journal of Health Economics, vol.22, issue.2, pp.151-185, 2003.
DOI : 10.1016/S0167-6296(02)00126-1

Y. L. Doz and M. Kosonen, Embedding Strategic Agility, Long Range Planning, vol.43, issue.2-3, pp.2-3, 2010.
DOI : 10.1016/j.lrp.2009.07.006

R. Durand, O. Bruyaka, and V. Mangematin, Do science and money go together? The case of the French biotech industry, Strategic Management Journal, vol.88, issue.1, pp.1281-1299, 2008.
DOI : 10.1002/smj.707

URL : https://hal.archives-ouvertes.fr/hal-00422650

M. Ebers and W. W. Powell, Biotechnology: Its origins, organization, and outputs, Research Policy, vol.36, issue.4, pp.433-437, 2007.
DOI : 10.1016/j.respol.2007.04.001

K. Eisenhardt, Building theories from case study research, Academy of Management Review, vol.14, issue.4, pp.532-550, 1989.

K. M. Eisenhardt and M. E. Graebner, THEORY BUILDING FROM CASES: OPPORTUNITIES AND CHALLENGES., Academy of Management Journal, vol.50, issue.1, pp.25-32, 2007.
DOI : 10.5465/AMJ.2007.24160888

M. S. Feldman, Organizational Routines as a Source of Continuous Change, Organization Science, vol.11, issue.6, pp.611-629, 2000.
DOI : 10.1287/orsc.11.6.611.12529

J. Fisken and J. Rutherford, Business models and investment trends in the biotechnology industry in Europe, Journal of Commercial Biotechnology, vol.8, issue.3, pp.191-199, 2002.
DOI : 10.5912/jcb431

L. Galambos and J. L. Sturchio, Pharmaceutical Firms and the Transition to Biotechnology: A Study in Strategic Innovation, Business History Review, vol.37, issue.02, 1998.
DOI : 10.1016/S0048-7333(97)00017-6

A. Gambardella and A. M. Mcgahan, Business-Model Innovation: General Purpose Technologies and their Implications for Industry Structure, Long Range Planning, vol.43, issue.2-3, pp.2-3, 2010.
DOI : 10.1016/j.lrp.2009.07.009

O. Gassmann and G. Reepmeyer, Organizing Pharmaceutical Innovation: From Science-based Knowledge Creators to Drug-oriented Knowledge Brokers, Creativity and Innovation Management, vol.24, issue.3, pp.233-245, 2005.
DOI : 10.1002/(SICI)1097-0266(199907)20:7<637::AID-SMJ42>3.3.CO;2-Q

B. Glaser and A. Strauss, The Discovery of Grounded Theory; Strategies for Qualitative Research, Nursing Research, vol.17, issue.4, 1967.
DOI : 10.1097/00006199-196807000-00014

C. Gilbert, UNBUNDLING THE STRUCTURE OF INERTIA: RESOURCE VERSUS ROUTINE RIGIDITY., Academy of Management Journal, vol.48, issue.5, pp.741-763, 1995.
DOI : 10.5465/AMJ.2005.18803920

G. S. Ginsburg and J. J. Mccarthy, Personalized medicine: revolutionizing drug discovery and patient care, Trends in Biotechnology, vol.19, issue.12, pp.491-496, 2001.
DOI : 10.1016/S0167-7799(01)01814-5

V. Govindarajan and A. K. Gupta, Strategic innovation: a conceptual Road Map Business Horizons, pp.44-48, 2001.

G. Gripsrud and K. Gronhaug, Structure and Strategy in Grocery Retailing: A Sociometric Approach, The Journal of Industrial Economics, vol.33, issue.3, pp.339-347, 1985.
DOI : 10.2307/2098541

E. G. Hansen, F. Grosse-dunker, and R. Reichwald, SUSTAINABILITY INNOVATION CUBE ??? A FRAMEWORK TO EVALUATE SUSTAINABILITY-ORIENTED INNOVATIONS, International Journal of Innovation Management, vol.13, issue.04, pp.683-713, 2009.
DOI : 10.1142/S1363919609002479

G. Herrigel, Large Firms, Small Firms and the Governance of Flexible Specialization: Baden- Württemberg and the Socialization of Risk, Country Competitiveness: Technology and the Organizing of Work, 1993.

C. W. Hill and F. T. Rothaermel, The performance of incumbent firms in the face of radical technological innovation, Academy of Management Review, vol.28, issue.2, p.257, 2003.

S. Hill and K. Johnson, Emerging Challenges and Opportunities in Drug Registration and Regulation in Developing Countries, 2004.

G. P. Hodgkinson, Cognitive Inertia in a Turbulent Market: the Case of UK Residential Estate Agents, Journal of Management Studies, vol.34, issue.6, pp.921-945, 1997.
DOI : 10.1111/1467-6486.00078

G. P. Hodgkinson and G. Wright, Confronting Strategic Inertia in a Top Management Team: Learning from Failure, Organization Studies, vol.8, issue.6, pp.947-977, 2002.
DOI : 10.1177/0170840602236014

M. M. Hopkins, P. A. Martin, P. Nightingale, A. Kraft, and S. Mahdi, The myth of the biotech revolution: An assessment of technological, clinical and organisational change, Research Policy, vol.36, issue.4, pp.566-589, 2007.
DOI : 10.1016/j.respol.2007.02.013

A. Kennard, Business models in the bioinformatics industry, 2009.

S. Klepper, Industry Life Cycles, Industrial and Corporate Change, vol.6, issue.1, pp.145-181, 1997.
DOI : 10.1093/icc/6.1.145

T. Kuhn, The Structure of Scientific Revolutions, 1962.

C. Lane and J. Probert, The External Sourcing of Technological Knowledge by US Pharmaceutical Companies: Strategic Goals and Inter???organizational Relationships, Industry & Innovation, vol.40, issue.1, pp.5-25, 2007.
DOI : 10.1080/00343400220122070

G. Laroia and S. Krishnan, Managing Drug Discovery Alliances for Success Research Technology Management, pp.42-50, 2005.

D. W. Light and R. Warbuton, Demythologizing the high costs of pharmaceutical research, BioSocieties, vol.276, issue.1, pp.34-50, 2011.
DOI : 10.1001/jama.1996.03540150055031

A. Lilico, Six Issues in Pharmaceuticals. Institute of Economic Affairs, pp.33-38, 2006.

H. A. Linstone, Three eras of technology foresight, Technovation, vol.31, issue.2-3, pp.69-76, 2011.
DOI : 10.1016/j.technovation.2010.10.001

J. D. Linton and S. T. Walsh, Integrating innovation and learning curve theory: an enabler for moving nanotechnologies and other emerging process technologies into production, R and D Management, vol.44, issue.7, pp.517-526, 2004.
DOI : 10.1016/0160-791X(85)90022-3

K. E. Marino, Developing consensus on firm competencies and capabilities., Academy of Management Perspectives, vol.10, issue.3, pp.40-51, 1996.
DOI : 10.5465/AME.1996.9704111473

P. Martin, M. Hopkins, and P. Nightingale, Living with 'Dinosaurs': What the case of genomics tells us about the role of New Technology Based Firms in the pharmaceutical industry. Working paper, 2010.

L. Mcgoey, J. Reiss, and A. Wahlberg, The global health complex, BioSocieties, vol.372, issue.3, pp.1-9, 2011.
DOI : 10.1016/S0140-6736(08)61485-3

M. B. Miles and M. Huberman, Qualitative Data Analysis: An Expanded Sourcebook, 1994.

C. P. Milne, US and European regulatory initiatives to improve R&D performance, Expert Opinion on Drug Discovery, vol.40, issue.1, pp.11-14, 2006.
DOI : 10.1517/17460441.1.1.11

J. Mittra, Life Science Innovation and the Restructuring of the Pharmaceutical Industry: Merger, Acquisition and Strategic Alliance Behaviour of Large Firms, Technology Analysis & Strategic Management, vol.19, issue.3, pp.279-301, 2007.
DOI : 10.1080/09537320701281540

M. Morris, M. Schindehutte, and J. Allen, The entrepreneur's business model: toward a unified perspective, Journal of Business Research, vol.58, issue.6, pp.726-735, 2005.
DOI : 10.1016/j.jbusres.2003.11.001

K. A. Munir and N. Phillips, The Birth of the 'Kodak Moment': Institutional Entrepreneurship and the Adoption of New Technologies, Organization Studies, vol.42, issue.11, pp.1665-1687, 2005.
DOI : 10.1177/0170840605056395

A. Nosella, G. Petroni, and C. Verbano, Characteristics of the Italian biotechnology industry and new business models: the initial results of an empirical study, Technovation, vol.25, issue.8, pp.841-855, 2005.
DOI : 10.1016/j.technovation.2004.02.002

K. Pavitt, Sectoral patterns of technical change: Towards a taxonomy and a theory, Research Policy, vol.13, issue.6, pp.343-375, 1984.
DOI : 10.1016/0048-7333(84)90018-0

A. M. Pettigrew, Longitudinal Field Research on Change: Theory and Practice, Organization Science, vol.1, issue.3, 1990.
DOI : 10.1287/orsc.1.3.267

R. Phaal, E. O-'sullivan, M. Routley, S. Ford, and D. Probert, A framework for mapping industrial emergence, Technological Forecasting and Social Change, vol.78, issue.2, pp.217-230, 2011.
DOI : 10.1016/j.techfore.2010.06.018

B. S. Piachaud, Outsourcing in the pharmaceutical manufacturing process: an examination of the CRO experience, Technovation, vol.22, issue.2, pp.81-90, 2002.
DOI : 10.1016/S0166-4972(01)00081-5

G. Pisano, Can science be a business? Lessons from, Biotech Harvard Business Review, vol.84, issue.10, pp.114-125, 2006.

A. Pollock, Transforming the critique of Big Pharma, BioSocieties, vol.25, issue.9, pp.106-118, 2011.
DOI : 10.1146/annurev.anthro.25.1.153

W. W. Powell, K. W. Koput, and L. Smith-doerr, Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology, Administrative Science Quarterly, vol.41, issue.1, pp.116-145, 1996.
DOI : 10.2307/2393988

C. K. Prahalad, The Blinders of Dominant Logic, Long Range Planning, vol.37, issue.2, pp.171-179, 2004.
DOI : 10.1016/j.lrp.2004.01.010

C. K. Prahalad and R. A. Bettis, The dominant logic: A new linkage between diversity and performance, Strategic Management Journal, vol.185, issue.6, pp.485-501, 1986.
DOI : 10.1002/smj.4250070602

A. S. Relman and M. Angell, America's Other Drug Problem, The New Republic, issue.16, pp.27-41, 2002.

F. T. Rothaermel, Technological Discontinuities and the Nature of Competition, Technology Analysis & Strategic Management, vol.1, issue.2, 2000.
DOI : 10.1093/icc/1.2.327

F. T. Rothaermel, Complementary assets, strategic alliances, and the incumbent???s advantage: an empirical study of industry and firm effects in the biopharmaceutical industry, Research Policy, vol.30, issue.8, pp.1235-1251, 2001.
DOI : 10.1016/S0048-7333(00)00142-6

F. T. Rothaermel, Incumbent's advantage through exploiting complementary assets via interfirm cooperation, Strategic Management Journal, vol.10, issue.6-7, pp.687-699, 2001.
DOI : 10.1002/smj.180

F. T. Rothaermel, Technological discontinuities and interfirm cooperation: what determines a startup's attractiveness as alliance partner?, IEEE Transactions on Engineering Management, vol.49, issue.4, p.388, 2002.
DOI : 10.1109/TEM.2002.806725

F. T. Rothaermel and C. W. Hill, Technological Discontinuities and Complementary Assets: A Longitudinal Study of Industry and Firm Performance, Organization Science, vol.16, issue.1, pp.52-70, 2005.
DOI : 10.1287/orsc.1040.0100

H. Rothman and A. Kraft, Downstream and into deep biology: Evolving business models in 'top tier' genomics companies, Journal of Commercial Biotechnology, vol.12, issue.2, pp.86-98, 2006.
DOI : 10.5912/jcb154

M. Roux and F. Xavier, Biologie Systémique: standards et modèles, 2007.

V. Sabatier, V. Mangematin, and T. Rousselle, From Recipe to Dinner: Business Model Portfolios in the European Biopharmaceutical Industry, Long Range Planning, vol.43, issue.2-3, pp.2-3
DOI : 10.1016/j.lrp.2010.02.001

V. Sabatier, V. Mangematin, and T. Rousselle, Orchestrating networks in the biopharmaceutical industry: small hub firms can do it, Production Planning & Control, vol.40, issue.2, pp.218-228
DOI : 10.1016/j.respol.2007.02.015

URL : https://hal.archives-ouvertes.fr/hal-00468340

F. Santos and K. M. Eisenhardt, Constructing Markets and Shaping Boundaries: Entrepreneurial Power in Nascent Fields, Academy of Management Journal, vol.52, issue.4, pp.643-671, 2009.
DOI : 10.5465/AMJ.2009.43669892

M. Sosna, R. N. Trevinyo-rodriguez, and S. R. Velamuri, Business Model Innovation through Trial-and-Error Learning, Long Range Planning, vol.43, issue.2-3, pp.383-407, 2010.
DOI : 10.1016/j.lrp.2010.02.003

C. Staropoli, Cooperation in R&D in the pharmaceutical industry ??? The network as an organizational innovation governing technological innovation, Technovation, vol.18, issue.1, pp.13-23, 1998.
DOI : 10.1016/S0166-4972(97)00107-7

M. Storper, The regional world: Territorial development in a global economy, 1997.

Y. Su and L. Hung, Spontaneous vs. policy-driven: The origin and evolution of the biotechnology cluster, Technological Forecasting and Social Change, vol.76, issue.5, pp.608-619, 2009.
DOI : 10.1016/j.techfore.2008.08.008

A. Taylor and C. E. Helfat, Organizational Linkages for Surviving Technological Change: Complementary Assets, Middle Management, and Ambidexterity, Organization Science, vol.20, issue.4, pp.718-739, 2009.
DOI : 10.1287/orsc.1090.0429

D. J. Teece, Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy, Research Policy, vol.15, issue.6, pp.285-305, 1986.
DOI : 10.1016/0048-7333(86)90027-2

D. J. Teece, Business Models, Business Strategy and Innovation, Long Range Planning, vol.43, issue.2-3, pp.172-174, 2010.
DOI : 10.1016/j.lrp.2009.07.003

N. Thumm, Strategic Patenting in Biotechnology, Technology Analysis & Strategic Management, vol.16, issue.4, pp.529-538, 2004.
DOI : 10.1080/0953732042000295829

M. L. Tushman and L. Rosenkopf, Organizational Determinants of Technological Change: Toward a Sociology of Technological Evolution, Research in Organizational Behavior, vol.14, pp.311-347, 1992.

J. M. Utterback and W. J. Abernathy, A dynamic model of process and product innovation, Omega, vol.3, issue.6, pp.639-656, 1975.
DOI : 10.1016/0305-0483(75)90068-7

M. Van-geenhuizen and L. Reyes-gonzalez, Does a clustered location matter for high-technology companies' performance? The case of biotechnology in the Netherlands, Technological Forecasting and Social Change, vol.74, issue.9, pp.1681-1696, 2007.
DOI : 10.1016/j.techfore.2006.10.009

V. Krogh, G. Erat, P. Macus, and M. , Exploring the Link between Dominant Logic and Company Performance, Creativity and Innovation Management, vol.9, issue.2, pp.82-93, 2000.
DOI : 10.1111/1467-8691.00160

S. Walsh and B. Kirchhoff, Entrepreneurs' opportunities and technology based markets, Technological Entrepreneurship, pp.17-30, 2002.

U. Weisenfeld, J. C. Reeves, and A. Hunck-meiswinkel, Technology management and collaboration profile: virtual companies and industrial platforms in the high-tech biotechnology industries, R and D Management, vol.31, issue.1, pp.91-100, 2001.
DOI : 10.1111/1467-9310.00199

S. G. Winter, Schumpeterian competition in alternative technological regimes, Journal of Economic Behavior & Organization, vol.5, issue.3-4, pp.287-320, 1984.
DOI : 10.1016/0167-2681(84)90004-0

S. Wunsch-vincent and G. Vickery, Working Party on the Information Economy, Digital Broadband Content: Music, OECD Report, 2004.

M. Yanez, T. M. Khalil, and S. T. Walsh, IAMOT and Education: Defining a Technology and Innovation Management (TIM) Body-of-Knowledge (BoK) for graduate education (TIM BoK), Technovation, vol.30, issue.7-8, 2010.
DOI : 10.1016/j.technovation.2010.03.007